George Yancopoulos - Jun 10, 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role: Bd. Co-Chair, President & CSO, Director
Signature: By: Richard Gluckselig as attorney-in-fact For: George D. Yancopoulos
Stock symbol: REGN
Transactions as of: Jun 10, 2024
Transactions value $: $0
Form type: 4
Date filed: 6/12/2024, 04:10 PM
Previous filing: May 17, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	REGN	Common Stock	Gift	$0	-75.8K	-100%	$0.00^*	0	Jun 10, 2024	by 2022 GRAT II
transaction	REGN	Common Stock	Gift	$0	+37.9K	+208.84%	$0.00	56K	Jun 10, 2024	by Children
holding	REGN	Common Stock						869K	Jun 10, 2024	Direct
holding	REGN	Common Stock						5.9K	Jun 10, 2024	By 401(k) Plan
holding	REGN	Common Stock						180K	Jun 10, 2024	By Trust for Chldn.	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	As investment trustee of trusts for the benefit of the reporting person's children.